Influenza A and RSV Samples | Human Biospecimens Online

Influenza A and RSV Samples

Banner Influenza A and RSV samples

Influenza A and RSV samples

Influenza Vs Respiratory syncytial virus (RSV) infection

Influenza, often known as Flu, is one of the most common seasonal diseases. It is caused by influenza virus types A, B, C, and D, RNA-type viruses from the Orthomyxoviridae family. Of all the virus types, influenza A and influenza B have been associated with numerous deadly outbreaks in the past. Influenza virus C is also the cause of mild to moderate respiratory infections.

RSV, also known as the respiratory syncytial virus, is a common respiratory virus that often causes mild, cold-like symptoms. RSV can be serious, especially for young children and elderly individuals, although most patients recover within a week or two. In children under one, RSV is the most frequent cause of bronchiolitis (inflammation of the tiny airways in the lung) and pneumonia (lung infection) in the United States.

How Influenza A and RSV Samples Are Used in Research

  • Influenza A and RSV samples are critical resources in virology and respiratory disease research, playing a key role in advancing our understanding of these common yet potentially severe infections. Researchers utilize these biospecimens to study the viral behavior, immune responses, and disease progression associated with Influenza A and RSV infections. By analyzing serum, plasma, and swab samples, scientists can gain insights into how these viruses infect the respiratory system, develop diagnostic tools, and formulate effective vaccines and therapies.
  • Vaccine Development: One of the primary uses of Influenza A and RSV biospecimens is in vaccine development. Researchers use these biospecimens to study the immune response in individuals previously exposed to these viruses, analyzing the production of IgM and IgG antibodies. This research helps identify viral antigens that can be targeted in vaccines, improving the effectiveness of influenza and RSV vaccines in different populations, especially among children and the elderly, who are at higher risk of severe illness.
  • Antiviral Drug Discovery: Influenza A and RSV samples are also used in drug discovery and testing. Researchers conduct in-vitro experiments using these biospecimens to evaluate the efficacy of antiviral compounds. By examining how these drugs interact with the virus in infected serum or plasma samples, scientists can identify potential treatment options that can reduce the severity and duration of respiratory infections, particularly in high-risk groups.
  • Diagnostic Test Development: The availability of well-characterized Influenza A and RSV samples enables researchers to develop more accurate and reliable diagnostic tests. By studying the viral RNA in swabs and plasma, researchers can design PCR and rapid antigen tests that can detect the presence of the virus quickly and efficiently. This is especially important for controlling the spread of influenza and RSV during seasonal outbreaks, where timely diagnosis can help prevent further transmission.
  • Immunology and Pathogenesis Studies: Research on Influenza A and RSV samples helps scientists understand the pathogenesis of these infections. By analyzing immune markers and cytokine levels in serum samples, researchers can explore how the body reacts to viral infections and what factors contribute to severe outcomes like bronchiolitis and pneumonia. This research is essential for developing targeted therapies and understanding why some individuals experience more severe symptoms than others.
  • Epidemiological Studies: Epidemiological research heavily relies on Influenza A and RSV samples to track the spread of these infections across different populations and regions. Biospecimens from various demographics help researchers understand how these viruses evolve and adapt, allowing public health officials to monitor trends and plan more effective interventions, such as vaccination campaigns or public awareness initiatives.

Ongoing Research Using Influenza A and RSV Samples

Ongoing research on Influenza A and RSV samples is making significant progress in several areas:
  • Vaccine Enhancement: Researchers are focused on developing universal vaccines that can offer broader protection against different strains of the Influenza A virus and RSV. By analyzing how existing vaccines perform in different population groups using human biospecimens, scientists aim to enhance vaccine formulations, making them more effective across age groups and viral variants.
  • Antiviral Resistance Studies: Another key area of research involves studying drug resistance in Influenza A and RSV. Researchers use biospecimens from patients to understand how these viruses develop resistance to antiviral treatments, such as Tamiflu for influenza. This helps guide the development of next-generation antiviral drugs that can overcome resistance and provide better treatment options.
  • Immunotherapy Research: Research into immunotherapies is also ongoing, using Influenza A and RSV samples to test how monoclonal antibodies and other immune-boosting therapies can help reduce the severity of infections. These studies are crucial for developing treatments that can be used in high-risk patients, such as infants, the elderly, and immunocompromised individuals.
  • Longitudinal Studies on Viral Evolution: Long-term studies are being conducted to track how the Influenza A virus and RSV evolve over time. By examining viral samples from multiple outbreaks, researchers can better understand how these viruses mutate and spread, leading to improved predictive models for future outbreaks.

Order Influenza A and RSV Infection Samples Online.

Central BioHub stands out as one of the most reliable biospecimen provider that millions of researchers worldwide rely on. As of 2017, We have served hundreds of well-known pharmaceutical, biotechnology, and diagnostic research organizations in different parts of the world.

Take advantage of Central BioHub's smartest online marketplace for human biospecimens to procure a wide range of Influenza A and Respiratory syncytial virus (RSV) infection samples for research and development. The specimens are thoroughly screened, well-annotated and immediately available for purchase!

Sample details:

  • Matrices: Serum, plasma and swabs in VTM

  • Tested for: Anti-Influenza A IgM/ IgG, Anti-RSV IgM/ IgG, Influenza A virus /RSV RT-PCR Test

  • Available details: Donor demographics, country of sample origin, medical history

Hurry up! Order research samples directly from our website:

Also, enjoy hassle-free ordering through the Central BioHub mobile app. Download now:

- iOS: https://apps.apple.com/in/app/central-biohub/id1618181521

-Android: https://play.google.com/store/apps/details?id=com.centralbiohub&hl=en

Also,explore advanced search options to order Influenza A and RSV samples online: Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameter.

Central BioHub - Order biospecimens online.

Central BioHub offers a wide range of Influenza A and RSV samples that are ethically collected from clinically confirmed patients for biomedical research. You can purchase serum, plasma, and swabs samples critically screened for Anti-Influenza A IgM/ IgG, Anti-RSV IgM/ IgG, Influenza A virus /RSV RT-PCR Test.
Human disease research always requires human specimens collected from persons of different ages, gender, ethnicity, and race. This enables the researcher to understand human biology, disease nature and its progression. Therefore guiding research on new drugs and diagnostic development.
You can order desired biospecimens directly from our website in a few steps. Browse our inventory, select your matching research samples, add them to the cart, and log into your customer account for payment and check-out. You will receive an order confirmation instantly to your registered E-mail ID.
Yes, you can make instant orders of Influenza A and RSV samples through our online marketplace. The samples are well preserved at our biobank and in perfect condition.